GO:1990529 glycosylphosphatidylinositol-mannosyltransferase I complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990529 describes the glycosylphosphatidylinositol-mannosyltransferase I (GPI-MT-I) complex, a heterodimeric enzyme that adds the first mannose to the GPI-anchor precursor.
• In yeast Saccharomyces cerevisiae the complex consists of Pbn1p and Gpi14p, while in mammals it is formed by PIG-X and PIG-M.
• The complex is conserved across eukaryotes, including Trypanosoma brucei where TbPBN1 partners with the catalytic subunit.
• Recent structural studies of the Candida glabrata and fungal GPI-MT-I complexes reveal the architecture and catalytic mechanism of the two-subunit enzyme.
• Loss of GPI-MT-I function blocks GPI-anchor biosynthesis, affecting cell-surface protein anchoring and viability.
• The complex is a potential antifungal and antiparasitic target because GPI biosynthesis is essential in fungi and protozoa.
Description
The glycosylphosphatidylinositol-mannosyltransferase I (GPI-MT-I) complex, annotated as GO:1990529, is a protein complex that catalyzes the transfer of the first mannose to the GPI-anchor precursor during glycosylphosphatidylinositol (GPI) biosynthesis. GPI anchors are glycolipid modifications that attach many cell-surface proteins to the membrane, and the GPI-MT-I step is an early and essential reaction in this pathway. The complex was initially defined in Saccharomyces cerevisiae as a heterodimer of Pbn1p and Gpi14p, and in mammals as a complex of PIG-X and PIG-M. Subsequent work identified a conserved heterodimeric architecture in Trypanosoma brucei, with TbPBN1 as the non-catalytic partner of the GPI-MT-I catalytic subunit. More recent structural studies of the Candida glabrata and other fungal GPI-MT-I complexes have provided mechanistic insight into how the two subunits cooperate to recognize the GPI precursor and perform mannosyl transfer. Because GPI-anchored proteins are involved in cell signaling, adhesion, and host-pathogen interactions, the GPI-MT-I complex is of interest for understanding eukaryotic membrane biology and for developing inhibitors against fungal and protozoan pathogens.
glycosylphosphatidylinositol-mannosyltransferase I complex At A Glance
| GO ID | GO:1990529 |
|---|---|
| GO term | glycosylphosphatidylinositol-mannosyltransferase I complex |
| Ontology | cellular_component |
| Synonym | GPI-MT-I complex |
| Major function | Transfer of the first mannose to the GPI-anchor precursor during GPI biosynthesis |
| Subunit composition (yeast) | Pbn1p and Gpi14p |
| Subunit composition (mammals) | PIG-X and PIG-M |
| Conservation | Conserved heterodimeric architecture in Trypanosoma brucei (TbPBN1 and catalytic subunit) |
| Structural insight | Structures of Candida glabrata and fungal GPI-MT-I complexes reveal subunit arrangement and catalytic mechanism |
What Is GO:1990529?
GO:1990529 (glycosylphosphatidylinositol-mannosyltransferase I complex) is a cellular component term describing a protein complex that transfers the four mannoses in the GPI-anchor precursor. In the yeast S. cerevisiae this complex consists of Pbn1p and Gpi14p, and in rat it consists of PIG-X and PIG-M. The complex is also known as the GPI-MT-I complex.
Why Is glycosylphosphatidylinositol-mannosyltransferase I complex Important in Cell Biology?
The GPI-MT-I complex is important because it catalyzes an early committed step in GPI-anchor biosynthesis, a pathway that anchors numerous proteins to the eukaryotic cell surface. Without a functional GPI-MT-I complex, cells cannot properly assemble GPI anchors, which impairs the surface expression of GPI-anchored proteins and can compromise cell viability. The complex is conserved from yeast to humans, and its essential role in fungi and protozoan parasites makes it a promising target for antifungal and antiparasitic drug development. In addition, understanding the structure and mechanism of the GPI-MT-I complex provides a framework for studying related glycosyltransferases and for interpreting disease-associated mutations in GPI pathway genes.
• Catalyzes the first mannosyl transfer step in GPI-anchor biosynthesis, a prerequisite for anchoring many cell-surface proteins.
• Conserved heterodimeric enzyme found in yeast, mammals, and protozoan parasites.
• Essential for fungal viability, making it a potential antifungal target.
• Required for GPI-anchored protein expression in Trypanosoma brucei, a human parasite.
• Structural studies provide a template for rational inhibitor design.
• Mutations in GPI pathway genes, including those encoding the GPI-MT-I subunits, can cause inherited disorders of GPI biosynthesis.
• The complex is a model system for studying glycosyltransferase mechanism and subunit cooperation.
• Its activity influences cell signaling, adhesion, and immune recognition through GPI-anchored proteins.
Structure and Composition of glycosylphosphatidylinositol-mannosyltransferase I complex
Heterodimeric architecture
In simple terms: The GPI-MT-I complex is made of two different protein subunits that work together.
The GPI-MT-I complex is a heterodimer. In Saccharomyces cerevisiae it consists of Pbn1p and Gpi14p, and in mammals it consists of PIG-X and PIG-M. A conserved heterodimeric architecture was also identified in Trypanosoma brucei, where TbPBN1 associates with the catalytic subunit. This two-subunit organization is a defining feature of the complex across eukaryotes.
Catalytic subunit
In simple terms: One subunit carries out the actual mannose transfer reaction.
The catalytic subunit of the GPI-MT-I complex is responsible for transferring mannose to the GPI precursor. In yeast this is Gpi14p, and in mammals it is PIG-M. The non-catalytic partner, Pbn1p in yeast or PIG-X in mammals, is required for the stability and function of the catalytic subunit. Structural studies of the Candida glabrata and fungal complexes have begun to reveal how the catalytic subunit binds its substrates and performs mannosyl transfer.
Accessory subunit function
In simple terms: The second subunit helps the catalytic subunit fold correctly and work properly.
The accessory subunit, Pbn1p in yeast or PIG-X in mammals, is essential for GPI-MT-I activity. Ashida et al. showed that PIG-X and Pbn1p are essential components of the complex, and that the catalytic subunit requires its partner for function. In Trypanosoma brucei, TbPBN1 is the conserved partner of the catalytic subunit, confirming that the heterodimeric arrangement is maintained in divergent eukaryotes.
Membrane association and topology
In simple terms: The complex is anchored in the endoplasmic reticulum membrane where GPI biosynthesis occurs.
GPI biosynthesis takes place at the endoplasmic reticulum membrane, and the GPI-MT-I complex is membrane-associated. The complex transfers mannose to the GPI-anchor precursor, which is itself a membrane-embedded glycolipid. Structural analyses of fungal GPI-MT-I complexes have provided insight into how the subunits are arranged relative to the membrane and how they access their lipid-linked substrate.
Conservation and structural insights
In simple terms: The complex looks similar in different organisms, and recent studies have shown its three-dimensional shape.
The GPI-MT-I complex is conserved across eukaryotes, from yeast to mammals to protozoan parasites. Recent structural studies of the Candida glabrata GPI-MT-I complex and other fungal complexes have revealed the overall architecture and provided mechanistic insights into substrate recognition and catalysis. These structures help explain how the two subunits cooperate and how the enzyme performs mannosyl transfer.
Key Genes Involved in GO:1990529 glycosylphosphatidylinositol-mannosyltransferase I complex
The following genes and proteins are the core components and conserved partners of the glycosylphosphatidylinositol-mannosyltransferase I complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIG-M (human) | Catalytic subunit of GPI-MT-I; transfers mannose to GPI precursor | Target for studying GPI biosynthesis and disease mutations |
| PIG-X (human) | Accessory subunit required for PIG-M stability and function | Essential partner; mutations may affect GPI anchor assembly |
| GP14 / GPI14 (S. cerevisiae) | Yeast catalytic subunit of GPI-MT-I | Model for fungal GPI biosynthesis and antifungal target |
| PBN1 (S. cerevisiae) | Yeast accessory subunit of GPI-MT-I | Required for Gpi14p function; conserved partner |
| TbPBN1 (T. brucei) | Conserved accessory subunit in Trypanosoma brucei | Confirms heterodimeric architecture in parasites |
| TbGPI14 (T. brucei) | Catalytic subunit in T. brucei | Parasite GPI biosynthesis and drug target |
| CgGPI14 (C. glabrata) | Catalytic subunit in Candida glabrata | Structural studies of fungal GPI-MT-I |
| CgPBN1 (C. glabrata) | Accessory subunit in Candida glabrata | Structural studies of fungal GPI-MT-I |
| PIG-A (human) | Earlier GPI pathway enzyme; not part of GPI-MT-I | Context for GPI pathway defects |
| PIG-C (human) | GPI pathway component; not part of GPI-MT-I | Context for GPI biosynthesis |
| PIG-H (human) | GPI pathway component; not part of GPI-MT-I | Context for GPI biosynthesis |
| PIG-P (human) | GPI pathway component; not part of GPI-MT-I | Context for GPI biosynthesis |
| DPM1 (human) | Dolichol-phosphate mannose synthase; supplies mannose donor | Indirectly supports GPI-MT-I activity |
| DPM2 (human) | Dolichol-phosphate mannose synthase subunit | Indirectly supports GPI-MT-I activity |
| DPM3 (human) | Dolichol-phosphate mannose synthase subunit | Indirectly supports GPI-MT-I activity |
| GPI1 (S. cerevisiae) | GPI pathway enzyme; not part of GPI-MT-I | Context for yeast GPI biosynthesis |
| GPI2 (S. cerevisiae) | GPI pathway enzyme; not part of GPI-MT-I | Context for yeast GPI biosynthesis |
How Is glycosylphosphatidylinositol-mannosyltransferase I complex Regulated?
The GPI-MT-I complex is regulated at the level of subunit availability and assembly. Ashida et al. demonstrated that PIG-X is essential for the function of PIG-M, indicating that the accessory subunit controls the activity of the catalytic subunit. In Trypanosoma brucei, TbPBN1 is required for the conserved heterodimeric architecture, suggesting that partner availability regulates complex formation. Structural studies of fungal GPI-MT-I complexes provide a basis for understanding how substrate binding and catalysis may be modulated. However, specific transcriptional or post-translational regulatory mechanisms for the GPI-MT-I complex are not well defined in the cited literature.
glycosylphosphatidylinositol-mannosyltransferase I complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIG-M | GPI biosynthesis defect; impaired GPI-anchored protein expression | PIG-M knockout human cell line |
| PIG-X | GPI biosynthesis defect; accessory subunit loss | PIG-X knockout human cell line |
| GPI14 (yeast) | Fungal viability; GPI anchor deficiency | S. cerevisiae gpi14 mutant |
| PBN1 (yeast) | Fungal viability; GPI anchor deficiency | S. cerevisiae pbn1 mutant |
| TbPBN1 | Trypanosome GPI anchor biosynthesis | T. brucei TbPBN1 knockout |
Inherited GPI biosynthesis disorders
Defects in GPI-anchor biosynthesis can cause inherited diseases characterized by neurological impairment and other symptoms. The GPI-MT-I complex, composed of PIG-M and PIG-X in mammals, catalyzes an early step in this pathway, and loss of its function would be expected to impair GPI-anchored protein expression. Ashida et al. established that PIG-X and PIG-M are essential components of GPI-MT-I, providing a molecular basis for understanding how mutations in these genes could contribute to GPI pathway disorders.
Fungal infections and antifungal targeting
GPI biosynthesis is essential in fungi, and the GPI-MT-I complex is a potential antifungal target. Structural studies of the Candida glabrata GPI-MT-I complex and other fungal complexes have revealed features that could be exploited for inhibitor design. Because the complex is conserved but has fungal-specific structural details, it may offer opportunities for selective inhibition.
Parasitic diseases
Trypanosoma brucei, the causative agent of African sleeping sickness, relies on GPI-anchored proteins for survival and immune evasion. The identification of TbPBN1 as the conserved partner of the GPI-MT-I catalytic subunit highlights the importance of this complex in the parasite. Targeting the GPI-MT-I complex could therefore be a strategy against trypanosomiasis.
From glycosylphosphatidylinositol-mannosyltransferase I complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of GPI-MT-I catalytic subunit loss on GPI-anchored proteins? | Knockout of PIG-M or GPI14 in human or yeast cells |
| How does the accessory subunit stabilize the catalytic subunit? | Knockout of PIG-X or PBN1 followed by protein stability assays |
| What is the structural basis of mannosyl transfer? | Point mutations in catalytic residues guided by structures |
| How is the complex assembled in the endoplasmic reticulum? | Tagged knock-in of PIG-M and PIG-X for imaging |
| Can overexpression rescue GPI anchor defects? | Overexpression of PIG-M and PIG-X in mutant cells |
| Is the complex essential in parasites? | Knockout of TbPBN1 in Trypanosoma brucei |
How to Study the glycosylphosphatidylinositol-mannosyltransferase I complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of GPI-MT-I subunit function | Testing essentiality in human or yeast cells |
| Complementation assay | Rescue of GPI anchor defect | Validating gene function |
| Cryo-EM / crystallography | Three-dimensional structure of the complex | Understanding subunit arrangement and catalysis |
| In vitro mannosyltransferase assay | Enzymatic activity of GPI-MT-I | Measuring mannose transfer to GPI precursor |
| Flow cytometry | Surface expression of GPI-anchored proteins | Functional readout of GPI-MT-I loss |
| Western blot | Protein stability of subunits | Assessing accessory subunit requirement |
| Site-directed mutagenesis | Role of specific residues | Mapping catalytic and interaction sites |
| Parasite genetic manipulation | Gene essentiality in T. brucei | Testing TbPBN1 function |
Genetic knockout and complementation
Knockout of GPI-MT-I subunits such as PIG-M, PIG-X, GPI14, or PBN1 followed by complementation with wild-type or mutant alleles is a standard approach to test function. Ashida et al. used such strategies to show that PIG-X and Pbn1p are essential components of the complex. Similar approaches in Trypanosoma brucei identified TbPBN1 as the conserved partner.
Structural biology
Cryo-electron microscopy and X-ray crystallography have been used to determine the structures of the Candida glabrata and other fungal GPI-MT-I complexes. These studies reveal subunit arrangement, substrate binding sites, and catalytic residues, providing a framework for mechanistic studies.
Biochemical assays for mannosyltransferase activity
In vitro mannosyltransferase assays using radiolabeled mannose donors and GPI precursor substrates can measure GPI-MT-I activity. Such assays were used to define the enzymatic function of the complex. Combining these assays with mutant subunits helps identify residues required for catalysis.
Cell-surface protein analysis
Flow cytometry and western blotting of GPI-anchored proteins can assess the functional consequences of GPI-MT-I loss. Because GPI-MT-I is required for GPI anchor biosynthesis, its disruption reduces surface expression of GPI-anchored proteins. This readout is useful for validating knockout and point-mutation models.
How CRISPR Can Be Used to Study GO:1990529 glycosylphosphatidylinositol-mannosyltransferase I complex
Knockout
CRISPR knockout of GPI-MT-I subunits such as PIG-M, PIG-X, GPI14, or PBN1 can be used to abolish complex function and assess effects on GPI-anchor biosynthesis and cell viability. Knockout models are valuable for confirming essentiality and for identifying compensatory pathways.
Point Mutation
CRISPR-mediated point mutations can introduce specific amino acid substitutions in catalytic or subunit-interaction residues identified by structural studies. Such models help dissect the catalytic mechanism and the role of individual residues in mannosyl transfer.
Knock-in
Knock-in of epitope tags or fluorescent proteins at endogenous GPI-MT-I subunit loci allows visualization and immunoprecipitation of the complex. Tagged knock-in models are useful for studying assembly, localization, and interaction partners.
Overexpression
CRISPR activation or cDNA overexpression of GPI-MT-I subunits can be used to test whether increased complex levels enhance GPI anchor biosynthesis or rescue partial defects. Overexpression models are also useful for producing recombinant complex for structural studies.
How EDITGENE Supports glycosylphosphatidylinositol-mannosyltransferase I complex Research
Researchers studying glycosylphosphatidylinositol-mannosyltransferase I complex-related genes often need to determine whether a candidate gene is causally involved in GPI anchor biosynthesis, cell viability, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for glycosylphosphatidylinositol-mannosyltransferase I complex research.
Frequently Asked Questions About glycosylphosphatidylinositol-mannosyltransferase I complex
What is GO:1990529?
GO:1990529 is the Gene Ontology term for the glycosylphosphatidylinositol-mannosyltransferase I complex, a protein complex that transfers the first mannose to the GPI-anchor precursor.
What genes are involved in the glycosylphosphatidylinositol-mannosyltransferase I complex?
In yeast the complex consists of Pbn1p and Gpi14p, and in mammals it consists of PIG-X and PIG-M. A conserved partner, TbPBN1, was identified in Trypanosoma brucei.
What is the function of the GPI-MT-I complex?
It catalyzes the transfer of the first mannose to the GPI-anchor precursor during GPI biosynthesis.
Where is the GPI-MT-I complex located?
The complex is associated with the endoplasmic reticulum membrane, where GPI biosynthesis occurs.
Is the GPI-MT-I complex conserved across species?
Yes, a conserved heterodimeric architecture has been identified in yeast, mammals, and Trypanosoma brucei.
What diseases are linked to GPI-MT-I complex dysfunction?
Defects in GPI biosynthesis can cause inherited disorders, and the complex is a potential target in fungal and parasitic infections.
How can I study the GPI-MT-I complex in the lab?
Common methods include CRISPR knockout, complementation assays, structural biology, and in vitro mannosyltransferase assays.
What is the structure of the GPI-MT-I complex?
Recent structural studies of Candida glabrata and other fungal complexes have revealed the heterodimeric architecture and catalytic mechanism.
Why is the GPI-MT-I complex a drug target?
Because GPI biosynthesis is essential in fungi and protozoan parasites, inhibitors of the complex could have antifungal or antiparasitic activity.
What cell models are available for GPI-MT-I research?
Knockout, point-mutation, knock-in, and overexpression models can be generated using CRISPR in human, yeast, or parasite cells.
Conclusion
The glycosylphosphatidylinositol-mannosyltransferase I complex (GO:1990529) is a conserved heterodimeric enzyme that performs the first mannosyl transfer step in GPI-anchor biosynthesis. Its subunits, PIG-M and PIG-X in mammals and Gpi14p and Pbn1p in yeast, are essential for GPI anchor assembly and cell-surface protein expression. Recent structural and functional studies in fungi and parasites have advanced our understanding of its mechanism and highlighted its potential as a drug target. Continued research using CRISPR-based models will further clarify its roles in health and disease.
References
- 1. Sun H et al.. 2025. Structural Insights into the Glycosylphosphatidylinositol Mannosyltransferase I Complex from Candida glabrata.. J Fungi (Basel) 11(11) PMID: 41295199
- 2. Cowton A et al.. 2022. Identification of TbPBN1 in Trypanosoma brucei reveals a conserved heterodimeric architecture for glycosylphosphatidylinositol-mannosyltransferase-I.. Mol Microbiol 117(2):450-461 PMID: 34875117
- 3. Liu J et al.. 2026. Structural and mechanistic insights into the fungal glycosylphosphatidylinositol mannosyltransferase I complex.. Proc Natl Acad Sci U S A 123(37):e2617140123 PMID: 42721083
- 4. Ashida H et al.. 2005. Mammalian PIG-X and yeast Pbn1p are the essential components of glycosylphosphatidylinositol-mannosyltransferase I.. Mol Biol Cell 16(3):1439-48 PMID: 15635094
